Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: Probable mediation by steroid receptors

Carcinogenesis

Volumn 19, Issue 12, 1998, Pages 2173-2180

  Liao, De Zhong Joshua ^a   Pantazis, Cooley G ^b   Hou, Xiaoying ^b   Li, Sara Antonia ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INCIDENCE; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; LATENT PERIOD; MALE; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; CARCINOGENS; ESTRADIOL; ESTROGENS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RABBITS; RATS; RATS, INBRED STRAINS; RECEPTORS, ANDROGEN; RECEPTORS, PROGESTERONE; TESTOSTERONE;

EID: 0032420154     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.12.2173     Document Type: Article

References (13)

1. Landis,S.H., Murray,T., Bolden,S. and Wingo,P.A. (1998) Cancer statistics, 1998. CA Cancer J. Clin., 48, 6-29.
2. Key,T.J.A. and Pike,M.C. (1988) The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur, J. Cancer Clin. Oncol., 24, 29-34.
3. Gradishar,W.J. and Morrow,M. (1996) Clinical aspects of breast cancer. In Vedeckis,W.V. (ed.) Hormones and Cancer. Birkhauser, Boston, MA, pp. 149-195.
4. Helzlsouer,K.J. and Couzi,R. (1995) Hormones and breast cancer. Cancer, 76 (suppl.), 2059-2063.
5. Feigelson,H.S. and Henderson,B.E. (1996) Estrogens and breast cancer. Carcinogencsis, 17, 2279-2284.
6. Dorgan,J.F., Longcope,C., Stephenson,H.E. Jr et al. (1997) Serum sex hormone levels are related to breast cancer risk in postmenopausal women. Environ. Health Perspect., 105, 583-585.
7. Zeleniuch-Jacquotte,A., Bruning,P.R, Bonfrer,J.M., Koenig,K.L., Shore,R.E., Kim,M.Y, Pastemack,B.S. and Toniolo,P. (1997) Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am. J. Epidemiol., 145, 1030-1038.
8. Sereto,G., Toniolo,P., Pisani,P., Recchione,C., Cavalleri,A., Fariselli,G., Totis,A., Di-Pietro,S. and Berrino,F. (1989) Androgens and breast cancer in premenopausal women. Cancer Res., 49, 471-476.
9. Secreto,G. and Zumoff,B. (1994) Abnormal production of androgens in women with breast cancer. Anticancer Res., 14, 2113-2118.
10. Kimura,N., Mizokami,A., Oonuma,T., Sasano,H. and Nagura,H. (1993) Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J. Histochem. Cytochem., 41, 671-678.
11. Thomas,D.B., Jimenez,L.M., McTiernan,A. et al. (1992) Breast cancer in men: Risk factors with hormonal implications. Am. J. Epidemiol., 135, 734-748.
12. Thomas,D.B. (1993) Breast cancer in man. Epidemiol. Rev., 15, 220-231.
13. Welsch,C.W. (1987) Rodent models to examine in vivo hormonal regulation of mammary gland tumorigenesis. In Medina,D., Kidwell,W., Heppner,G. and Anderson,E. (eds) Cellular and Molecular Biology of Mammary Cancer. Plenum Press, New York, NY, pp. 163-179.